COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,492 Articles (22,862 medRxiv, 8,630 bioRxiv)

Most recent first Previous |  Page 10: Articles 91-100  | Next

Cross-coronavirus host susceptibility loci influence disease severity through immune mediators
Risemberg, E. L., Leist, S. R., Schaefer, A., Kamat, K. D., Bell, T. A., Hock, P., Jensen, K. L., Linnertz, C. L., Miller, D. R., Shaw, G. D., Pardo-Manuel de Villena, F., Baric, R. S., Ferris, M. T., Valdar, W.
10.64898/2026.03.23.713300 — Posted: 2026-03-25
IL-1β and TNF drive endothelial dysfunction and coagulopathy in acute COVID-19.
Mostafavi, H., Hill, B., Nalkurthi, C., Bader, S. M., Zhu, Y., Yu, A., Hansbro, P. M., Doerflinger, M., Johansen, M. D., Short, K. R., Chew, K. Y., Gordon, E. J., Labzin, L. I.
10.64898/2026.03.21.713333 — Posted: 2026-03-25
Experimental SARS-CoV-2 infection using horseshoe bats
Usui, K., Tsuda, M., Uriu, K., Fujita, S., Kashima, Y., Suzuki, Y., Wang, L., Tanaka, S., Ito, J., Sato, K.
10.64898/2026.03.19.712934 — Posted: 2026-03-25
Shifts in the pathogen spectrum and epidemiology of respiratory tract infections in the post-COVID-19 era: A study from Quzhou, Eastern China
Yang, R., Wang, M., Lyu, L., You, J., Huang, S., Zhan, B.
10.64898/2026.03.20.26348947 — Posted: 2026-03-24
SARS-CoV-2 Defective Viral Genomes from Distinct Genomic Regions Drive Divergent Interferon Responses
Brennan, J. W., Spandau, S., Wang, X., Aull, H., Connor, S., Pryhuber, G., Mariani, T. J., Serra-Moreno, R., Sun, Y.
10.64898/2026.03.19.712870 — Posted: 2026-03-24
Resistome, Virulome, Mobilome, And Biosynthetic Gene Clusters Adaptations of Acinetobacter Baumannii Mexican Strains Across the Pre- and of the COVID-19 Period: Insights from Whole-Genome Sequencing
Alejo, M. A., Lozano Gamboa, M. S., Munoz Gomez, B. E., Hernandez Magro Gil, K. G., Garcia Contreras, R., Whitaker, R., Palacios Marmolejo, A., Ceapa, C. D.
10.64898/2026.03.22.712163 — Posted: 2026-03-23
Microtesla Magnetic Therapy for cognitive impairment in post-acute sequelae of SARS CoV-2: A randomized controlled feasibility study
Canori, A., Watson, E., Patel, D., Fiorentino, A., Santiago, C., Maltz, D., Gurfein, B., Putrino, D., Becker, J.
10.64898/2026.03.18.26348530 — Posted: 2026-03-23
Feasibility, Acceptability, and Cost of Community-Based Self-monitoring among Sex Workers Testing Positive for COVID-19 in Zimbabwe: A Mixed-methods Study.
Kabonga, I., Mangenah, C., Watadzaushe, C., Madanhire, C., Ruhode, N., Dunkley, Y., Karin, H., Corbett, E. L., Cowan, F. M., Sibanda, E. L.
10.64898/2026.03.16.26348020 — Posted: 2026-03-23
Physiotherapy service during the COVID-19 pandemic in Nepal: An onsite survey and the lived experience among clinicians
Shakya, N. R., Dahal, S., Shrestha, N., Webb, G., Stensdotter, A.-K.
10.64898/2026.03.19.26348776 — Posted: 2026-03-22
SARS-CoV-2 and the Pandemic Surge in Invasive Group A Streptococcal Disease
Fisman, D., Lee, C. E., Wilson, N., Barton, M., Mann, S. K., Tuite, A.
10.64898/2026.03.19.26348823 — Posted: 2026-03-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).